Skip to main content

Together we are beating cancer

Donate now

Cancer News

Cancer type

Showing 12 out of 2893 results
A group of microscopic glioblastoma cells against a black background. The cells are coloured red, with their steroid receptors marked in green.

Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet. Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet.

by Fiona MacLeod, Tim Gunn | Analysis | 20 February 2026

20 February 2026

A close up shot of a person putting the bowel cancer test sample in the sample holder to send off by mail for testing.

NHS England has announced it will up the sensitivity of bowel cancer screening tests, a change that should help save more lives from the country's second leading cause of cancer death. NHS England has announced it will up the sensitivity of bowel cancer screening tests, a change that should help save more lives from the country's second leading cause of cancer death.

by Tim Gunn | News | 26 January 2026

26 January 2026

A computer generated microscopic image of purple lung cancer cells with a genetic mutation.
  • Science & Technology
  • Health & Medicine

Our defining research stories of 2025

2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year. 2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year.

by Amal Iman | In depth | 19 December 2025

19 December 2025

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

A microscopic image of two lung cancer cells dividing, held together by a very thin bridge of cytoplasm.

With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine. With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine.

by Amal Iman | News | 17 November 2025

17 November 2025